Accessibility Statement

We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies such as automated tools, keyboard-only navigation, and screen readers.

We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and guidelines will help make the website more user friendly for all people.

Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website. If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.

Thank you. We hope you enjoy using our website.

Skip to Main Content

North Central Baptist Expands in Early Lung Cancer Detection

Aug 2, 2018

(San Antonio, Texas, July 30, 2018) - North Central Baptist Hospital has begun offering a comprehensive new technology developed to improve the early detection of lung cancer. The Veran SPiN Thoracic Navigation System™ gives physicians practicing at North Central Baptist Hospital another tool to help locate and diagnose lung cancer at earlier stages for patients.

Aldo Ambrosio Parodi, M.D., Pulmonary Disease Specialist at NCBH, performed the first procedure on July 12th and is excited about the positive impact this new procedure will have on patients. “With this new technology, North Central Baptist Hospital offers a more efficient way to find lung nodules at earlier stages which is the key to improving patient outcomes.” said Dr. Parodi. “Using an electromagnetic navigational bronchoscopic method allows the biopsy of lung nodules and masses for patients with hard-to-reach lesions in their lungs.”

The early detection of lung cancer, while it is still localized, greatly affects survival rates for patients. With early detection, there is an 88% survival rate at ten years and a 92% survival rate with the immediate removal of the lesion. Before the recent development of electromagnetic navigation, only 16% of lung cancer patients have been diagnosed at an early stage.**

The SPiN System™ technology uses electromagnetic navigation, which is similar to a car’s global positioning system (GPS). It begins with a CT scan of the patient’s lungs to automatically create a route to a suspicious lesion. This allows physicians to easily biopsy and place markers for planned treatment using a catheter inserted via the patient’s airway.

The SPiN System™offers patients a minimally-invasive approach to navigate to lesions located deep in the lungs. The procedure requires no incision, avoids the need for higher-risk procedures to remove lung lesions, and as an added benefit, allows less radiation exposure for patients, physicians, and staff.

Find a Doctor

Need a doctor for your care?

Sign Up for Health Tips

Get our advice and upcoming events about weight, pain, heart and more.